logo

Shariah compliance overview

Not Halal

Capricor Therapeutics, Inc. (CAPR) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death…

Capricor Therapeutics, Inc. (CAPR) operates in the Healthcare sector, in the Biotechnology industry.

Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing securities and assets.

Business Activity
100.00%Limit 5%Fail
Interest-bearing debt
0.59%Limit 30%Pass
Interest-bearing securities and assets
51.92%Limit 30%Fail
Dividend purification
100.00%Share of dividends to give to charityPurification calculator

Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Capricor Therapeutics, Inc. (CAPR). Current Akinda screening label: Not Halal.